SEC Form 4 · accession 0001144204-16-098458
CALADRIUS BIOSCIENCES, INC. · CLBS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert A Preti
Officer — See Remarks · Director
Period of report
Apr 25, 2016
Accepted (ET)
May 2, 2016 · 9:49 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000320017
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Apr 25, 2016 | F | 1,632 | $0.68 | D | 261,823 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 52,250 shares of unvested restricted stock.
Remarks
Senior Vice President, Manufacturing and Technical Operations and Chief Technology Officer